A Georgia urgent care center has agreed to pay $1.6 million to end a lawsuit that accuses them of violating the False Claims Act after the defendants submitted Medicare claims that were improperly coded according to the U.S. Attorney's Office for the Northern District of Georgia. In a release issued... Read More »
University of Miami to pay $22 million to settle claims of defrauding federal Medicare program
The University of Miami has agreed to pay $22 million to settle three lawsuits claiming the University’s hospital system administered medically unnecessary lab tests, knowingly took advantage of the Medicare program and forced one of their hospitals to inflate reimbursement claims.
The lawsuits outlined three illegal activities by the University’s healthcare system. The first claimed the University of Miami improperly billed many of its Medicare patients who received services from its newly converted healthcare facilities. Under Medicare, a hospital system can convert physician offices into official hospital facilities but must notify the patients that the cost of services will change, if not likely increase. The lawsuit claims that the University failed to notify its Medicare patients, resulting in a gross amount of improper billing to the federal Medicare system demanding higher payments for their services.
The second lawsuit claimed that the University routinely billed the Medicare system for “unnecessary laboratory tests” anytime the Miami Transplant Institute (MTI) performed a kidney transplant. The lawsuit found that whenever MTI checked in a patient, their “electronic ordering system triggered a pre-set ‘protocol’ of tests” regardless of if the tests were essential or not. As in the first lawsuit, this resulted in not only unwarranted exams for the patients but excessive billing to the federal government, costing the American taxpayers.
The final lawsuit claimed that the University caused Jackson Memorial Hospital, a facility within its system, “to submit inflated claims for reimbursement for pre-transplant laboratory testing” by controlling the hospital’s decision to purchase the equipment. The University withheld UM’s surgeons and Department of Surgery resources unless the hospital complied.
The final lawsuit claimed that the University of Miami’s actions towards the Jackson Memorial Hospital, a facility within its system, forced the hospital to file “inflated claims for reimbursement for pre-transplant laboratory testing.” The University withheld its surgeons and Department of Surgery personnel and resources from working at the hospital until Jackson Memorial Hospital bought the laboratory tests from the University of Miami at inflated costs.
In a statement made by Acting Assistant Attorney General Brian M. Boynton for the Justice Department’s Civil Division, he argues that this type of billing for “medically unnecessary services” all “contribute to the soaring cost of health care.”
University whistleblowers utilize the False Claims Act’s qui tam provisions
The False Claims Act (FCA) was enacted in 1863 during the American Civil War when the U.S. Congress realized that suppliers were delivering second-rate goods and services to the Union Army. The FCA remains the strongest and most successful anti-fraud legislation in the country. The Act mandates that any false claim requiring money or property from the U.S. government or a contractor who would be reimbursed by the federal government would be liable for damages and penalty payments for each false claim.
In 1986, the FCA was amended to increase the amount owed by the perpetrator from double to treble damages incurred by the U.S. government for the false claim. It also raised the penalties of each false claim to a range between $5,000 and $10,000. The Act has been amended several times since 1986, and its current penalty is set at a range between $5,500 and $11,000 for each false claim in addition to the treble damages.
The FCA was the country’s first whistleblower protection. The qui tam provision, also known as the whistleblower provision, allows private individuals, known as relators, to sue on behalf of the government for false claims. This clause is the most powerful of the Act. The individuals are then able to share in any recovery collected as a result of the lawsuit. In this case, four executives of the University of Miami filed the three separate lawsuits and will receive anywhere from 15 – 25% of the $22 million settlement. The exact amount has yet to be released.
The ongoing three cases against the University of Miami were unsealed in November 2020, but the final settlement was revealed on May 10, 2021. In addition to the $22 million settlement, the University of Miami also must enter into an extensive corporate integrity agreement with the Health and Human Services Office for five years.
Related Articles
A hospital in Southern Illinois has agreed to settle a whistleblower lawsuit that claimed they were overcharging patients for urgent care services. The settlement agreement was announced by the U.S. Attorney’s Office for the Central District of Illinois. In the statement, officials explain that St. Elizabeth’s Hospital of the Hospital... Read More »
The Department of Justice has demonstrated a renewed vigor in pursuing healthcare fraud investigations in recent years. The DOJ boasts that it has recovered more than $149 million in 2022 just in COVID-19-related fraud actions. In 2021, they pursued actions totaling more than $1.4 billion in alleged losses. The DOJ’s... Read More »
An Orlando cardiologist has been ordered to pay $6.75 million to resolve allegations that he knowingly performed unnecessary medical procedures. Dr. Ashish Pal was accused of violating the False Claims Act after he knowingly submitted false claims to federal health care programs for medically unnecessary ablations and vein stent procedures,... Read More »